Your browser doesn't support javascript.
loading
Development of a novel shared decision making aid for primary immunodeficiency diseases.
Tzivelekis, Spiros; Orange, Jordan; Poulos, Christine; Meckley, Lisa M; Peay, Holly; Sutphin, Jessie; Hernandez-Trujillo, Vivian P; Wasserman, Richard L.
Affiliation
  • Tzivelekis S; Takeda, 650 East Kendall Street, Cambridge, MA 02142, USA.
  • Orange J; Columbia University Irving Medical Center, 632 W168th Street, New York, NY 10032, USA.
  • Poulos C; RTI Health Solutions, 3040 Cornwallis Road, Research Triangle Park, Durham, NC 27709, USA.
  • Meckley LM; Takeda, 650 East Kendall Street, Cambridge, MA 02142, USA.
  • Peay H; RTI International, 3040 Cornwallis Road, Research Triangle Park, Durham, NC 27709, USA.
  • Sutphin J; Duke Clinical Research Institute, Duke University, 200 Morris Street, Durham NC 27705-3976, USA.
  • Hernandez-Trujillo VP; RTI Health Solutions, 3040 Cornwallis Road, Research Triangle Park, Durham, NC 27709, USA.
  • Wasserman RL; Allergy & Immunology Care Center of South Florida, 16371 NW 67th Ave, Miami Lakes, FL 33014, USA.
Immunotherapy ; 15(9): 647-656, 2023 06.
Article in En | MEDLINE | ID: mdl-37158075
Shared decision making and developing a decision aid Shared decision making happens when patients and doctors work together to choose treatment options based on a patient's concerns, preferences, goals and values, as well as medical information. The aim of this project was to develop a decision aid to help patients with primary immunodeficiency diseases (PID), in which part of the body's immune system is missing or doesn't function correctly. This will allow patients to better understand and communicate with the healthcare team on their preferences about immunoglobulin treatments, which fight infection by boosting antibody (protein) levels in the blood. The authors talked to experts and reviewed existing information to decide what treatment features the aid should consider. Patients with PID then tested the aid, and changes were made based on their feedback. Doctors specializing in treating PID also provided their feedback. The final aid was judged to be helpful and easy to use by the participants. With further research, this aid could be used to help inexperienced patients better understand what immunoglobulin treatment features are most important to them, and support shared decision-making between patients and their doctors.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Decision Support Techniques / Primary Immunodeficiency Diseases Type of study: Prognostic_studies / Qualitative_research Aspects: Patient_preference Limits: Adult / Humans Language: En Journal: Immunotherapy Journal subject: ALERGIA E IMUNOLOGIA / TERAPEUTICA Year: 2023 Document type: Article Affiliation country: United States Country of publication: United kingdom

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Decision Support Techniques / Primary Immunodeficiency Diseases Type of study: Prognostic_studies / Qualitative_research Aspects: Patient_preference Limits: Adult / Humans Language: En Journal: Immunotherapy Journal subject: ALERGIA E IMUNOLOGIA / TERAPEUTICA Year: 2023 Document type: Article Affiliation country: United States Country of publication: United kingdom